Abstract:BACKGROUND:Nasopharyngeal carcinoma (NPC) is a highly invasive malignancy which has unique characteristics when found among individuals from certain ethnic or geographic populations. The role and molecular mechanism of Polo-like kinase 1 (PLK1) in NPC remain yet to be clarified. Hence, the aim of this study is to identify the clinical implications of PLK1 in NPC based on gene chip, tissue microarray, and other silico approaches.METHODS:Relevant data related to PLK1 levels in NPC was screened for by searching in SRA, GEO, ArrayExpress, Oncomine and throughout the existing literature on this topic. The raw data about gene chips were normalized by using an RMA algorithm provided by "Limma" package. Furthermore, the "SVA" package of R software was used to remove the batch effect and data from the same platform were merged into one part. The differential expression levels of PLK1 between NPC and non-NPC tissues were extracted and analyzed with the Student's t-test. Meta-analyses were used to calculate the standard mean difference and sROC. Furthermore, in-house immunohistochemistry was performed with tissue microarrays. Weighted correlation network analysis was used to identify the PLK1-related genes. Several bioinformatic evaluations, including the Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, and protein-protein interactions, were also performed to assess the PLK1-related pathways.RESULTS:The tissue microarray and gene chips indicated that the PLK1 levels clearly had an up-regulating trend as compared to the non-cancerous controls. These trends were observed in both the single study and the comprehensive meta-analysis. The area under the sROC curve in the NPC tissues was 0.87, with pooled sensitivity and specificity at 0.950 and 0.710, respectively, based on 393 NPC tissues and 83 non-cancerous controls. A total of 144 genes were identified as co-expressed genes of PLK1 in NPC and were mainly enriched in the "cell cycle" pathway. Among the genes related to the cell cycle, CDK1, CCNA2 and CCNB2 were all closely related to PLK1 expression level.CONCLUSIONS:PLK1 may play a potential oncogenic role in the tumorigenesis and development of NPC. Since several PLK1 inhibitors have been developed, it is believed that the PLK1 inhibitors have great therapeutic potential in clinic applications for NPC patients.

Interaction of serine/threonine protein kinase Plk1 and transcriptional repressor NAC1

Involvement of Polo-like Kinase 1 (plk1) in Mitotic Arrest by Inhibition of Mitogen-activated Protein Kinase-Extracellular Signal-regulated Kinase-Ribosomal S6 Kinase 1

The Balance of Polo-like Kinase 1 in Tumorigenesis

Polo-like Kinase-1 Triggers Histone Phosphorylation by Haspin in Mitosis.

Construction of the recombinant adenovirus mediated short hairpin RNA to silence Polo-like kinase 1 and its biomedical application

Polo-like kinase 1 is essential for early embryonic development and tumor suppression.

Advances in Research of Ser/Thr Kinase Polo-Like Kinase 1

Plk1-mediated Phosphorylation of UAP56 Regulates the Stability of UAP56

Involvement of Polo-like Kinase 1 (plk1) in Mitotic Arrest by Inhibition of Mitogen-activated Protein Kinase-Extracellular Signal-regulated Kinase-Ribosomal S6 Kinase 1 (MEK-ERK-RSK1) Cascade*

Plk1 inhibition delays mitotic entry revealing prophase-specific changes to the phosphoproteome

PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressor

Plk1 Interacts with RNF2 and Promotes Its Ubiquitin‑dependent Degradation.

TTDN1 is a Plk1-interacting Protein Involved in Maintenance of Cell Cycle Integrity

Identification of potential functions of polo-like kinase 1 in male reproductive development of the oriental river prawn (Macrobrachium nipponense) by RNA interference analysis

Interaction between nucleosome assembly protein 1-like family members

Systematic analysis of the Plk-mediated phosphoregulation in eukaryotes.

Up-regulation of Polo-like Kinase 1 in Nasopharyngeal Carcinoma Tissues: a Comprehensive Investigation Based on RNA-sequencing, Gene Chips, and In-House Tissue Arrays.

The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma

Phospho-Pon Binding-Mediated Fine-Tuning of Plk1 Activity

Carcinogenic Roles of the Protein Kinase Plk1

Targeting Plk1 sensitizes pancreatic cancer to immune checkpoint therapy